$498.68
+9.20(1.88%)
Mkt Cap $14.2B
$277.23
$620.59
52-Week Range
At A Glance
1
Medpace Holdings, Inc.
2
Revenue is primarily driven by Oncology (30.4%) and Metabolic (24.2%).
3
Most recently: , including the press release attached as Exhibit 99.1, is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exch (2026-02-09).
$14.2B
Market Cap
$2.5B
Revenue
$453M
Net Income
Employees5,900
Fundamentals
How The Business Makes Money
Revenue by Segment
Oncology30.4%($2.0B)
Metabolic24.2%($1.6B)
Other19.1%($1.2B)
Cardiology10.2%($664M)
Central Nervous System9.1%($597M)
Antiviral And Anti Infective7%($455M)
Activity
Analyst View
Company Profile
CIK0001668397
ISINUS58506Q1094
CUSIP58506Q109
Phone513 579 9911
Address5375 Medpace Way, Cincinnati, OH, 45227, US
SEC EDGAR